NORVASC

This brand name is authorized in United States. It is also authorized in Australia, Austria, Brazil, Canada, Croatia, Cyprus, Ecuador, Estonia, Finland, Germany, Hong Kong SAR China, Israel, Italy, Japan, Lithuania, Netherlands, New Zealand, Poland, Romania, Singapore, South Africa, Turkey.

Active ingredients

The drug NORVASC contains one active pharmaceutical ingredient (API):

1	Amlodipine UNII 864V2Q084H - AMLODIPINE BESYLATE
	Amlodipine is a calcium ion influx inhibitor of the dihydropyridine group (slow channel blocker or calcium ion antagonist) and inhibits the transmembrane influx of calcium ions into cardiac and vascular smooth muscle.
	Read more about Amlodipine

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
NORVASC Tablet	MPI, US: SPL/PLR	FDA, National Drug Code (US)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
C08CA01	Amlodipine	C Cardiovascular system → C08 Calcium channel blockers → C08C Selective calcium channel blockers with mainly vascular effects → C08CA Dihydropyridine derivatives
Discover more medicines within C08CA01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AU	Pharmaceutical Benefits Scheme	2751T, 2752W
BR	Câmara de Regulação do Mercado de Medicamentos	552820020062817, 552820020062917, 552820020063017, 552820020063117, 552820020063217, 552820020063317, 552820020063417
CA	Health Products and Food Branch	00878928, 00878936
DE	Bundesinstitut für Arzneimittel und Medizinprodukte	00011162, 01951097, 02038923, 03553805, 03573908, 04220709, 04220715, 05500718, 06344309, 07701326, 07763267, 07763273, 08646687, 10167267, 11279979, 11331059, 12368797, 17757351
EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	2942-MEE-0817, 2943-MEE-0817
EE	Ravimiamet	1018527, 1018538, 1551428, 1551439, 1551440, 1551451, 1551462, 1551473, 1551484, 1551495, 1551507, 1551518, 1551529, 1551530, 1551541, 1551552, 1553576, 1553587, 1553598, 1553600, 1553611, 1553622, 1553633, 1553644, 1553655, 1553666, 1553677, 1553688, 1553699, 1553701, 1553712, 1553723, 1553734, 1553745, 1553756, 1553767, 1553778, 1553789, 1553790, 1580521, 1738481, 1738492, 1738504, 1738515, 1738526, 1738537, 1738548, 1738559, 1738560, 1738571, 1738582, 1738593, 1738605, 1738616, 1738627, 1738638, 1738649, 1738650, 1738661, 1738672, 1738683, 1738694, 1738706, 1738717, 1738728, 1830585, 1830596
FI	Lääkealan turvallisuus- ja kehittämiskeskus	005876, 005926
HK	Department of Health Drug Office	33731, 33732, 65946
HR	Agencija za lijekove i medicinske proizvode	HR-H-228396781, HR-H-497864837
IL	מִשְׂרַד הַבְּרִיאוּת	8039, 8040
IT	Agenzia del Farmaco	027428010, 027428022, 039670017, 039670082, 043348010, 043348022, 043348034, 043348046, 043663018, 043663032, 043704016, 043704030, 043817016, 043994019, 043995012, 043995036, 044428011, 044428023, 044428035, 044428047, 044428050, 044503023, 044628016
JP	医薬品医療機器総合機構	2171022F1029, 2171022F2025, 2171022F3048, 2171022F4044, 2171022F5032, 2171022F6039
LT	Valstybinė vaistų kontrolės tarnyba	1002174, 1002175, 1016095, 1016096, 1033535, 1033536, 1059809, 1059810, 1065779, 1065780, 1065781, 1065782, 1065783, 1065784, 1065785, 1065786, 1065787, 1065788, 1065789, 1065790, 1065791, 1065792, 1065793, 1065794, 1065795, 1065796, 1065797, 1065798, 1065799, 1065800, 1065801, 1065802, 1065803, 1065804, 1065805, 1065806, 1065807, 1065808, 1065809, 1065810, 1065811, 1065812, 1065813, 1065814, 1065815, 1065816, 1065817, 1065818, 1065819, 1065820, 1065821, 1065822, 1067191, 1079663
NL	Z-Index G-Standaard, PRK	30961, 30988
NZ	Medicines and Medical Devices Safety Authority	5586, 5588
PL	Rejestru Produktów Leczniczych	100048357, 100048363, 100396561, 100396578, 100401090, 100401115, 100405165, 100407460, 100411361, 100413319, 100414649, 100425558, 100425587, 100430312, 100430424, 100450987
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W67200001, W67200002, W67200003, W67200004, W67200005, W67200006, W67200007, W67200008, W67200009, W67200010, W67200011, W67201001, W67201002, W67201003, W67201004, W67201005, W67201006, W67201007, W67201008, W67201009, W67201010, W67202001, W67202002, W67202003, W67202004, W67202005, W67202006, W67202007, W67202008, W67202009, W67202010, W67202011, W67202012, W67202013, W67202014, W67202015, W67202016, W67203001, W67203002, W67203003, W67203004, W67203005, W67203006, W67203007, W67203008, W67203009, W67203010, W67203011, W67203012, W67203013, W67203014, W67203015, W67203016, W67203017
SG	Health Sciences Authority	05277P, 05278P, 14502P, 14503P
TR	İlaç ve Tıbbi Cihaz Kurumu	8699532011701, 8699532011718, 8699532014078, 8699532014085, 8699532015327, 8699532015334, 8699532055767, 8699532059635, 8699532059642, 8699532059659, 8699532059666
US	FDA, National Drug Code	0069-1520, 0069-1530, 0069-1540, 55289-103
ZA	Health Products Regulatory Authority	Y/7.1/26, Y/7.1/27